Skip to content
10-Q

Quarterly Report

ZYVERSA THERAPEUTICS, INC. ZVSA

0001493152-25-024263

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 17, 2025 8.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 7.74M sh
Shares Diluted Q3 2025 · Sep 30, 2025 5.24M sh
Shares Diluted Q3 2025 · Sep 30, 2024 988.38K sh
Shares Diluted Q3 2025 · Sep 30, 2024 816.29K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$4.7M
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$6.3M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$11.73M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.1M
Stockholders Equity Q3 2025 · Mar 31, 2025 $8.13M
Stockholders Equity Q3 2025 · Dec 31, 2024 $8.52M
Stockholders Equity Q3 2025 · Sep 30, 2024 $7.03M
Stockholders Equity Q3 2025 · Jun 30, 2024 $8.62M
Stockholders Equity Q3 2025 · Mar 31, 2024 $11.22M
Stockholders Equity Q3 2025 · Dec 31, 2023 $11.07M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.77M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $12.77M
Total Liabilities Q3 2025 · Dec 31, 2024 $12.08M
Current Assets Q3 2025 · Sep 30, 2025 $995.53K
Current Assets Q3 2025 · Dec 31, 2024 $1.72M
Total Assets Q3 2025 · Sep 30, 2025 $1.04M
Total Assets Q3 2025 · Dec 31, 2024 $20.6M
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.56
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.43
Eps Diluted Q3 2025 · Sep 30, 2024 −$9.79
Eps Basic Q3 2025 · Sep 30, 2025 −$2.56
Eps Basic Q3 2025 · Sep 30, 2025 −$4.63
Eps Basic Q3 2025 · Sep 30, 2024 −$2.43
Eps Basic Q3 2025 · Sep 30, 2024 −$9.79
Sga Expense Q3 2025 · Sep 30, 2025 $1.74M
Sga Expense Q3 2025 · Sep 30, 2025 $5.26M
Sga Expense Q3 2025 · Sep 30, 2024 $1.83M
Sga Expense Q3 2025 · Sep 30, 2024 $6.19M
Rd Expense Q3 2025 · Sep 30, 2025 $365.05K
Rd Expense Q3 2025 · Sep 30, 2025 $1.03M
Rd Expense Q3 2025 · Sep 30, 2024 $436.04K
Rd Expense Q3 2025 · Sep 30, 2024 $1.66M
Net Income Q3 2025 · Sep 30, 2025 −$19.81M
Net Income Q3 2025 · Sep 30, 2025 −$24.27M
Net Income Q3 2025 · Jun 30, 2025 −$2.21M
Net Income Q3 2025 · Mar 31, 2025 −$2.26M
Net Income Q3 2025 · Sep 30, 2024 −$2.4M
Net Income Q3 2025 · Sep 30, 2024 −$7.99M
Net Income Q3 2025 · Jun 30, 2024 −$2.76M
Net Income Q3 2025 · Mar 31, 2024 −$2.83M
Operating Income Q3 2025 · Sep 30, 2025 −$20.75M
Operating Income Q3 2025 · Sep 30, 2025 −$24.94M
Operating Income Q3 2025 · Sep 30, 2024 −$2.27M
Operating Income Q3 2025 · Sep 30, 2024 −$7.85M